These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29187439)

  • 1. Expression of FAS-L Differs from Primary to Relapsed Low-grade Gliomas and Predicts Progression-free Survival.
    Werner JM; Kuhl S; Stavrinou P; Röhn G; Krischek B; Blau T; Goldbrunner R; Timmer M
    Anticancer Res; 2017 Dec; 37(12):6639-6648. PubMed ID: 29187439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.
    Bourkoula E; Mangoni D; Ius T; Pucer A; Isola M; Musiello D; Marzinotto S; Toffoletto B; Sorrentino M; Palma A; Caponnetto F; Gregoraci G; Vindigni M; Pizzolitto S; Falconieri G; De Maglio G; Pecile V; Ruaro ME; Gri G; Parisse P; Casalis L; Scoles G; Skrap M; Beltrami CA; Beltrami AP; Cesselli D
    Stem Cells; 2014 May; 32(5):1239-53. PubMed ID: 24375787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
    Chen KT; Wu TW; Chuang CC; Hsu YH; Hsu PW; Huang YC; Lin TK; Chang CN; Lee ST; Wu CT; Tseng CK; Wang CC; Pai PC; Wei KC; Chen PY
    J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro neurosphere formation correlates with poor survival in glioma.
    C Jayakrishnan P; H Venkat E; M Ramachandran G; K Kesavapisharady K; N Nair S; Bharathan B; Radhakrishnan N; Gopala S
    IUBMB Life; 2019 Feb; 71(2):244-253. PubMed ID: 30393962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACTC1 as an invasion and prognosis marker in glioma.
    Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
    J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.
    Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
    World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death Receptor 6 as a Prognostic Marker in Low-grade Glioma.
    Stegmann SK; Kuhl S; Im NG; Diem-Dinh DT; Goertz L; Goldbrunner R; Timmer M
    Anticancer Res; 2022 Mar; 42(3):1237-1245. PubMed ID: 35220214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAM109B plays a tumorigenic role in low-grade gliomas and is associated with tumor-associated macrophages (TAMs).
    Zhang Z; Xiao Y; Zhao S; Liu J; Zeng J; Xiao F; Liao B; Shan X; Zhu H; Guo H
    J Transl Med; 2024 Sep; 22(1):833. PubMed ID: 39256832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma.
    Jeong SY; Lim SM
    Nucl Med Biol; 2012 Oct; 39(7):977-81. PubMed ID: 22483845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of androgen receptor expression in gliomas.
    Zhang C; Zhao N; Khan R; Hung MY; Zhang C; Wang S; Wang TJC; Lin C
    Sci Rep; 2024 Sep; 14(1):22122. PubMed ID: 39333688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade Gliomas.
    Fan X; Wang Y; Zhang C; Liu L; Yang S; Wang Y; Liu X; Qian Z; Fang S; Qiao H; Jiang T
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
    Patil V; Mahalingam K
    Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.
    Eisenstat DD; Pollack IF; Demers A; Sapp MV; Lambert P; Weisfeld-Adams JD; Burger PC; Gilles F; Davis RL; Packer R; Boyett JM; Finlay JL
    J Neurooncol; 2015 Feb; 121(3):573-81. PubMed ID: 25431150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression levels of Fas/Fas-L mRNA in human brain glioma stem cells.
    Tao J; Qiu B; Zhang D; Wang Y
    Mol Med Rep; 2012 May; 5(5):1202-6. PubMed ID: 22344564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of YAP1 and pSTAT3-S727 and their prognostic value in glioma.
    Sang W; Xue J; Su LP; Gulinar A; Wang Q; Zhai YY; Hu YR; Gao HX; Li X; Li QX; Zhang W
    J Clin Pathol; 2021 Aug; 74(8):513-521. PubMed ID: 33020176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients.
    Xu T; Qin R; Zhou J; Yan Y; Lu Y; Zhang X; Fu D; Lv Z; Li W; Xia C; Hu G; Ding X; Chen J
    PLoS One; 2012; 7(10):e48415. PubMed ID: 23119009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen-G overexpression predicts poor clinical outcomes in low-grade gliomas.
    Fan X; Wang Y; Zhang C; Liu X; Qian Z; Jiang T
    J Neuroimmunol; 2016 May; 294():27-31. PubMed ID: 27138095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.
    Gressot LV; Doucette T; Yang Y; Fuller GN; Manyam G; Rao A; Latha K; Rao G
    Oncotarget; 2017 Feb; 8(8):12695-12704. PubMed ID: 27074575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.